1st International Seminar of the National Service for the Prevention and Rehabilitation of Drug and Alcohol Consumption (SENDA)
Health and social responses to drug problems: A European guide
EMCDDA webinar: Health and social responses to cannabis problems in Europe — time for a paradigm shift?
Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers
Implementing quality standards for drug services and systems: a six-step guide to support quality assurance
Prison and drugs in Europe: current and future challenges
Final meeting of the project ‘Minimal drug-treatment data set: data collection in Western Balkans'
Using the evidence-based model for improving opioid agonist treatment scale-up in Ukraine
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
EMCDDA releases third trendspotter study on COVID-19 and drugs
Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance
Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications
Impact of the COVID-19 epidemic on drug markets, substance use patterns, and delivery of harm reduction and treatment services in Ukraine